BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 25602187)

  • 1. [Myotonic dystrophies: clinical presentation, pathogenesis, diagnostics and therapy].
    Finsterer J; Rudnik-Schöneborn S
    Fortschr Neurol Psychiatr; 2015 Jan; 83(1):9-17. PubMed ID: 25602187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
    Meola G
    Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myotonic dystrophies.
    Huang CC; Kuo HC
    Chang Gung Med J; 2005 Aug; 28(8):517-26. PubMed ID: 16265841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms.
    Meola G; Cardani R
    Biochim Biophys Acta; 2015 Apr; 1852(4):594-606. PubMed ID: 24882752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myotonic dystrophy types 1 and 2.
    Ashizawa T; Sarkar PS
    Handb Clin Neurol; 2011; 101():193-237. PubMed ID: 21496635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
    Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
    Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.
    Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H
    Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular aspects of the myotonic dystrophies: a review.
    Machuca-Tzili L; Brook D; Hilton-Jones D
    Muscle Nerve; 2005 Jul; 32(1):1-18. PubMed ID: 15770660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2.
    Timchenko L
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myotonic dystrophies type 1 and 2: anesthetic care.
    Veyckemans F; Scholtes JL
    Paediatr Anaesth; 2013 Sep; 23(9):794-803. PubMed ID: 23384336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myotonic dystrophy: from bench to bedside.
    Johnson NE; Heatwole CR
    Semin Neurol; 2012 Jul; 32(3):246-54. PubMed ID: 23117949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger Myotonic Dystrophy type 1-like phenotypes and activate autophagocytosis genes.
    Cerro-Herreros E; Chakraborty M; Pérez-Alonso M; Artero R; Llamusí B
    Sci Rep; 2017 Jun; 7(1):2843. PubMed ID: 28588248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.
    Bachinski LL; Udd B; Meola G; Sansone V; Bassez G; Eymard B; Thornton CA; Moxley RT; Harper PS; Rogers MT; Jurkat-Rott K; Lehmann-Horn F; Wieser T; Gamez J; Navarro C; Bottani A; Kohler A; Shriver MD; Sallinen R; Wessman M; Zhang S; Wright FA; Krahe R
    Am J Hum Genet; 2003 Oct; 73(4):835-48. PubMed ID: 12970845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myotonic Dystrophies: A Genetic Overview.
    Soltanzadeh P
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of muscle atrophy in myotonic dystrophies.
    Timchenko L
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2280-7. PubMed ID: 23796888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population.
    Vallo L; Bonifazi E; Borgiani P; Novelli G; Botta A
    Mol Cell Probes; 2005 Feb; 19(1):71-4. PubMed ID: 15652222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myotonic dystrophy type 2.
    Finsterer J
    Eur J Neurol; 2002 Sep; 9(5):441-7. PubMed ID: 12220374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunction of protein homeostasis in myotonic dystrophies.
    Meola G; Jones K; Wei C; Timchenko LT
    Histol Histopathol; 2013 Sep; 28(9):1089-98. PubMed ID: 23536431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myotonic dystrophy: RNA pathogenesis comes into focus.
    Ranum LP; Day JW
    Am J Hum Genet; 2004 May; 74(5):793-804. PubMed ID: 15065017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.